(Q34571948)

3 August 2017

1 reference

title

Minimal residual disease in leukaemia patients (English)

1 reference

3 August 2017

0 references

1 reference

T Szczepański

1

1 reference

3 August 2017

A Orfão

2

1 reference

3 August 2017

V H van der Velden

3

1 reference

3 August 2017

J F San Miguel

4

1 reference

3 August 2017

J J van Dongen

5

1 reference

3 August 2017

1 July 2001

1 reference

Lancet Oncology Commission

3 August 2017

1 reference

3 August 2017

2

1 reference

3 August 2017

409-417

1 reference

3 August 2017

7

1 reference

Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900418-6

7 January 2021

BIOMED-1 Concerted Action report: Flow cytometric characterization of CD7+ cell subsets in normal bone marrow as a basis for the diagnosis and follow-up of T cell acute lymphoblastic leukemia (T-ALL)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900418-6

7 January 2021

Flow cytometric analysis of the Vbeta repertoire in healthy controls

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900418-6

7 January 2021

Induction of clinical remission in T-large granular lymphocyte leukemia with cyclosporin A, monitored by use of immunophenotyping with Vbeta antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900418-6

7 January 2021

Molecular and flow cytometric analysis of the Vbeta repertoire for clonality assessment in mature TCRalphabeta T-cell proliferations

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900418-6

7 January 2021

Immunophenotypic and immunogenotypic characteristics of TCRgammadelta+ T cell acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900418-6

7 January 2021

Phenotypic changes in acute myeloid leukaemia: implications in the detection of minimal residual disease

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900418-6

7 January 2021

Detection of minimal residual disease in acute leukemia by flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900418-6

7 January 2021

Low frequency of reverse transcription polymerase chain reaction-detectable chromosome aberrations in relapsed acute myeloid leukaemia: implications for detection of minimal residual disease

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900418-6

7 January 2021

Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900418-6

7 January 2021

Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900418-6

7 January 2021

Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900418-6

7 January 2021

Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900418-6

7 January 2021

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900418-6

7 January 2021

Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900418-6

7 January 2021

Prognostic value of immunophenotypic detection of minimal residual disease in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900418-6

7 January 2021

Detection and quantification of residual disease in chronic myelogenous leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900418-6

7 January 2021

The rate and kinetics of molecular response to donor leucocyte transfusions in chronic myeloid leukaemia patients treated for relapse after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900418-6

7 January 2021

Disappearance of AML1-MTG8(ETO) fusion transcript in acute myeloid leukaemia patients with t(8;21) in long-term remission

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900418-6

7 January 2021

Detection of CBFB/MYH11 transcripts in patients with inversion and other abnormalities of chromosome 16 at presentation and remission

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900418-6

7 January 2021

Real-time RT-PCR for the detection and quantification of AML1/MTG8 fusion transcripts in t(8;21)-positive AML patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900418-6

7 January 2021

Minimal residual disease detection after myeloablative chemotherapy in chronic lymphatic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900418-6

7 January 2021

Persistence of circulating t(14;18)-positive cells in long-term remission after radiation therapy for localized-stage follicular lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900418-6

7 January 2021

Peripheral blood stem cell contamination in mantle cell non-Hodgkin lymphoma: the case for purging?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900418-6

7 January 2021

10.1016/S1470-2045(00)00418-6

Identifiers

DOI

1 reference

3 August 2017

1 reference